KANCERA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.522 SEK | +6.73% |
|
+7.79% | -66.51% |
| 03/05 | Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects | CI |
| 23/02 | Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Kancera AB
f4bd2294570.qvZZj9JFz5qcgt7IkU6wUgur5lSaDH6ANUC66pGH3kM.zLIv654AnNuk052r5yvRAWrylw3RajPSYxaKicmyj3Lzrmrshj2a4qmvjw~c3f2275e61cf06ce96dbfcf58a4b3368
Upcoming events on Kancera AB
Past events on Kancera AB
| 23/02/2024 | Q4 2023 Earnings Release |
| 17/11/2023 | Q3 2023 Earnings Release |
| 18/08/2023 | Q2 2023 Earnings Release |
| 25/05/2023 | Annual General Meeting |
| 19/05/2023 | Q1 2023 Earnings Release |
| 21/02/2023 | FY 2022 Earnings Release |
| 18/11/2022 | Q3 2022 Earnings Release |
| 23/08/2022 02:30 am | Interim 2022 Earnings Release |
| 20/05/2022 12:00 pm | Q1 2022 Earnings Release |
| 18/02/2022 01:05 pm | FY 2021 Earnings Release |
| 19/11/2021 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,36 0,10 258% | 3,22 0,00 - | 0,00 | 0,75 0,50 50.6% | 1,04 0,60 72.5% |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -51,6 -53,1 2.87% | -62,0 -54,8 -13.22% |
|
EBIT Million SEK | Released Forecast Spread | -45,9 -45,0 -2.05% | -35,7 -38,0 6.18% | 0,00 | -51,9 -53,4 2.75% | -65,0 -58,1 -11.95% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -52,5 -53,7 2.26% | -64,9 -58,4 -11.11% |
|
Net income Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -45,7 | -52,5 -53,7 2.26% | -64,9 -58,4 -11.11% |
|
EPS SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -0,82 | -0,90 -1,00 10% | -0,49 -0,70 30% |
| Announcement Date | 22/02/19 | 21/02/20 | 18/02/22 | 21/02/23 | 23/02/24 |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,44 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -17,1 -10,2 -67.62% | -18,2 -13,5 -35.06% | -10,5 -17,7 40.8% | -19,0 -12,0 -58.22% | -20,3 | -20,3 | -20,3 |
|
EBIT Million SEK | Released Forecast Spread | -17,2 -10,3 -66.86% | -18,3 -13,6 -34.73% | -10,5 -17,7 40.42% | -19,0 -12,0 -58.22% | -20,3 | -20,3 | -20,3 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -17,5 -10,3 -69.89% | -18,2 -13,6 -33.74% | -10,7 -17,7 39.36% | -18,5 -12,0 -53.9% | -20,3 | -20,3 | -20,3 |
|
EPS SEK | Released Forecast Spread | -0,22 -0,13 -69.23% | -0,23 -0,16 -43.75% | -0,13 -0,22 40.91% | -0,23 -0,15 -53.33% | -0,20 | -0,17 | -0,17 |
| Announcement Date | 19/05/23 | 18/08/23 | 17/11/23 | 23/02/24 | - | - | - |
More events
Past sector events for Kancera AB
| 03/05/2024 04:30 pm | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KAN Stock
- Calendar Kancera AB
